Four years after its initial announcement to revive the Today contraceptive sponge, the company responsible for its rebirth finally has released the product in Canada and says it is pressing for Food and Drug (FDA) approval to market the device over the counter in the United States.
Scientists recently conducted an international survey to explore womens willingness to use a contraceptive that induces amenorrhea.
Epidemiological evidence presented at a recent Bethesda, MD-based National Cancer Institute (NCI) workshop could help end a longstanding debate on the question of induced abortion and risk of breast cancer.
The news is in from the worlds first large-scale trial of a HIV vaccine, and it isnt good: The vaccine failed to achieve a statistically significant reduction of HIV infection within its study population as a whole.
Its back to the research drawing board in the search for more treatment options for genital herpes. A clinical trial of an experimental drug, resiquimod, has been suspended since preliminary data showed it was not as effective as expected.
A randomized, diet-controlled interventional study demonstrates that moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels.
The findings of this study, which are consistent with the results of studies in animals, as well as in vitro and epidemiologic dietary studies, suggest that current levels of vitamin A supplementation and food fortification in many Western countries may need to be reassessed.
The metabolic syndrome affects more than 1 in 5 Americans and is increased substantially in Mexican Americans and by several modifiable lifestyle factors.
Initiation of antihypertensive treatment involving ACE inhibitors in older subjects, particularly men, appears to lead to better outcomes than treatment with diuretic agents, despite similar reductions of blood pressure.
